Additional file 2. Post hoc analysis of differences in MMSE and RAVLT between amyloid-positive and amyloid-negative SCD and MCI patients
BACKGROUND: Quality of life (QoL) is an important outcome from the perspective of patients and their...
Background: Quality of life (QoL) is an important outcome from the perspective of patients and their...
BACKGROUND: Quality of life (QoL) is an important outcome from the perspective of patients and their...
Examining the differences between amyloid-positive and amyloid-negative subjects. (PDF 2073 kb
Table S2. Cut-offs used for defining pre-clinical Alzheimer’s disease according biomarkers positivit...
Voxel-based morphometric analysis of global atrophy in the dementia with Lewy bodies group or the Al...
Results of multiple linear regression models without control for confounding variables. Values are β...
Results of multiple linear regression models with control for confounding variables. Values are β co...
Items of ADAS-Cog variants. Supplementary table providing details about items of ADAS-Cog variants. ...
Variables and measures from the RightTimePlaceCare study data set, based on factors associated with ...
Details of the sensitivity analyses performed and results obtained. (DOCX 770 kb
Figure S1. Subgroup analysis according to mean age of participants. (PNG 1040 kb
Detailed information about the AD-associated SNPs under analysis plan 1 (males and females). (XLSX ...
STROBE Statement—Checklist of items that should be included in reports of cohort studies. (PDF 28 kb
Background: Quality of life (QoL) is an important outcome from the perspective of patients and their...
BACKGROUND: Quality of life (QoL) is an important outcome from the perspective of patients and their...
Background: Quality of life (QoL) is an important outcome from the perspective of patients and their...
BACKGROUND: Quality of life (QoL) is an important outcome from the perspective of patients and their...
Examining the differences between amyloid-positive and amyloid-negative subjects. (PDF 2073 kb
Table S2. Cut-offs used for defining pre-clinical Alzheimer’s disease according biomarkers positivit...
Voxel-based morphometric analysis of global atrophy in the dementia with Lewy bodies group or the Al...
Results of multiple linear regression models without control for confounding variables. Values are β...
Results of multiple linear regression models with control for confounding variables. Values are β co...
Items of ADAS-Cog variants. Supplementary table providing details about items of ADAS-Cog variants. ...
Variables and measures from the RightTimePlaceCare study data set, based on factors associated with ...
Details of the sensitivity analyses performed and results obtained. (DOCX 770 kb
Figure S1. Subgroup analysis according to mean age of participants. (PNG 1040 kb
Detailed information about the AD-associated SNPs under analysis plan 1 (males and females). (XLSX ...
STROBE Statement—Checklist of items that should be included in reports of cohort studies. (PDF 28 kb
Background: Quality of life (QoL) is an important outcome from the perspective of patients and their...
BACKGROUND: Quality of life (QoL) is an important outcome from the perspective of patients and their...
Background: Quality of life (QoL) is an important outcome from the perspective of patients and their...
BACKGROUND: Quality of life (QoL) is an important outcome from the perspective of patients and their...